经颈动脉ViV TAVI联合生物瓣膜断裂术治疗小号Mitroflow瓣膜并ECMO救援
本文报告一例86岁男性退行性19 mm Mitroflow生物瓣患者,经颈动脉入路使用20 mm Myval瓣行ViV TAVI,术后瓣膜扩张不足且跨瓣压差升高,遂用18 mm非顺应性球囊行生物瓣膜断裂术,术后出现心肌顿抑和血流动力学崩溃,经VA ECMO支持48小时后成功脱机并稳定出院。
要点
- 小号外科生物瓣行ViV TAVI需警惕残余压差高和冠脉阻塞风险。
- 经颈动脉入路可作为复杂解剖条件下的替代入路选择。
- 生物瓣膜断裂术可改善瓣膜扩张,但需ECMO standby应对血流动力学崩溃。
核心结论
- 首例报道经颈动脉ViV TAVI联合BVF治疗19 mm Mitroflow生物瓣并成功以ECMO救援。
- 复杂高危解剖需重视入路规划、瓣膜选择和ECMO备用。
研究设计与样本
- 个案报道,1例86岁男性退行性19 mm Mitroflow生物瓣患者。
主要发现
- 经颈动脉入路置入20 mm Myval瓣后出现显著扩张不足和跨瓣压差升高。
- 使用18 mm非顺应性球囊行BVF后瓣膜完全扩张且压差降低。
- BVF后不久发生心肌顿抑和血流动力学崩溃,需紧急VA ECMO支持。
- ECMO支持48小时后成功脱机,患者稳定出院。
临床怎么用
- 小号外科生物瓣退行性变行ViV TAVI时应评估BVF可行性并备用ECMO。
- 经颈动脉入路可作为复杂解剖条件下的替代选择。
局限性
- 单一个案报道,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valve-in-valve transcatheter aortic valve implantation (ViV TAVI) in small surgical bioprostheses presents unique challenges due to high residual gradients and risk of coronary obstruction. CASE SUMMARY: We report a case of an 86-year-old man with a degenerated Mitroflow 19 mm valve who underwent ViV TAVI via transcarotid access using a 20 mm Myval valve. Significant underexpansion was observed post-implantation, with elevated transvalvular gradients. Bioprosthetic valve fracture (BVF) was performed using an 18 mm non-compliant balloon, resulting in full valve expansion and gradient reduction. Shortly after BVF, the patient developed myocardial stunning and hemodynamic collapse, requiring urgent veno-arterial extracorporeal membrane oxygenation (VA ECMO) support. Extracorporeal membrane oxygenation was successfully weaned after 48 hours, and the patient was discharged in stable condition. CONCLUSION: This is the first reported case of transcarotid ViV TAVI with BVF in a 19 mm Mitroflow bioprosthesis, successfully rescued with ECMO. The report highlights the importance of appropriate access planning, valve selection, and ECMO standby in complex high-risk anatomies.
引用
- Mosquera VX, Martinez-Comendador JM, Cuenca-Castillo JJ, et al. Breaking the Limits: Transcarotid Valve-in-Valve Transcatheter Aortic Valve Implantation With Bioprosthetic Valve Fracture in a Small Mitroflow and Extracorporeal Membrane Oxygenation Rescue. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41557847. doi:10.1093/icvts/ivaf298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。